ArticleFrontiers in oncology2025
Interpretable machine learning models based on multi-dimensional fusion data for predicting positive surgical margins in robot-assisted radical prostatectomy: a retrospective study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to develop and validate interpretable machine learning (ML) models based on multi-dimensional fusion data for predicting positive surgical margins (PSM) in robot-assisted radical prostatectomy (RARP). Methods: Patients who underwent RARP at our institution between January 2016 and July 2025 were enrolled. Demographic, clinical, biopsy pathology data, and MRI-derived anatomical features (measured using ITK-SNAP on axial, sagittal, and coronal planes) were collected. Feature selection was performed using intraobserver and interobserver correlation coefficients (ICCs), low-variance filtering, univariable logistic regression, Spearman's correlation analysis, the least absolute shrinkage and selection operator (LASSO) algorithm, and the Boruta algorithm. Six ML models were constructed, with performance evaluated using area under the curve (AUC), calibration curves, and decision curve analyses (DCA) to identify the optimal model. Five-fold and ten-fold cross-validation were used to assess the optimal model's generalizability, and its interpretability was evaluated via Shapley Additive exPlanations (SHAP) analysis. Results: A total of 347 patients were included, comprising a training set (n=193, January 2016-December 2024), validation set (n=84, January 2016-December 2024), and test set (n=70, January 2025-July 2025). From 164 initial features, 7 key features were retained through a four-step screening. The Random Forest (RF) model outperformed other models, achieving AUCs of 0.99 (95% CI: 0.97-1.00) in the training set, 0.88 (95% CI: 0.80-0.95) in the validation set, and 0.97 (95% CI: 0.94-1.00) in the test set. Calibration curve and decision curve analyses confirmed its strong clinical utility. Five-fold cross-validation for the RF model showed fold-specific AUCs of 0.82-0.92, with a mean AUC of 0.87 (95% CI: 0.84-0.90). Ten-fold cross-validation showed fold-specific AUCs of 0.80-0.99, with a mean AUC of 0.88 (95% CI: 0.83-0.93). SHAP analysis revealed five novel spatial anatomical features (such as Sagittal plane-posterior spatial anatomical structure index, Coronal plane-Left anatomical structure interval) were negatively associated with PSM risk, while the number of positive biopsy cores and clinical tumor stage were positively associations. Conclusions: Multi-dimensional fusion data combined with ML models improves PSM prediction accuracy in RARP. The RF model, with excellent performance and interpretability, shows promise for preoperative PSM risk stratification, facilitates optimized clinical decision-making, and supports personalized treatment discussions during preoperative planning, but requires prospective and external validation before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.